FDA Clears Haemonetics PerQseal Elite Vascular Closure System

The U.S. Food and Drug Administration (FDA) has cleared the Haemonetics PerQseal Elite Vascular Closure System. This regulatory action indicates that the device can be marketed in the U.S. for its intended use, which is to achieve hemostasis in femoral arterial punctures.